Long non-coding RNAs are differentially expressed in hepatocellular carcinoma cell lines with differing metastatic potential

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 23, 2014, Pages 10513-10524

  Fang, Ting Ting ^a   Sun, Xiao Jing ^a   Chen, Jie ^a   Zhao, Yan ^a   Sun, Rui Xia ^a   Ren, Ning ^a   Liu, Bin Bin ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Expression; Hepatocellular carcinoma; Long non coding RNA; Organ specific metastasis; RP5 1014O16.1

Indexed keywords

LONG UNTRANSLATED RNA; MESSENGER RNA;

GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HEPG2 CELL LINE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; METASTASIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, LONG NONCODING; RNA, MESSENGER;

EID: 84921715343     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.23.10513     Document Type: Article

References (78)

1. Barabasi AL (2004). Network biology: Understanding the cell's functional organization. Nat Rev Genet, 5, 101-15.
2. Bartel DP (2009). MicroRNAs: Target Recognition and Regulatory Functions. Cell, 136, 215-33.
3. Berteaux N, Aptel N, Cathala G, et al (2008). A novel H19 antisense rna overexpressed in breast cancer contributes to paternal IGF2 expression. Mol Cell Biol, 28, 6731-45.
4. Bertone P, Stolc V, Royce TE, et al (2004). Global identification of human transcribed sequences with genome tiling arrays. Science, 306, 2242-6.
5. Braconi C, Valeri N, Kogure T, et al (2011). Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proc Nat Acad Sci USA, 108, 786-91.
6. Bussemakers M, Verhaegh GW, Karthaus H, et al (1999). DD3: A new prostate-specific gene, highly overexpressed in prostate cancer. Cancer Res, 59.
7. Cabili MN, Trapnell C, Goff L, et al (2011). Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev, 25, 1915-27.
8. Chen W, Bocker W, Brosius J, et al (1997). Expression of neural BC200 RNA in human tumours. J Pathol, 183, 345-51.
9. Da Sacco L, Baldassarre A, Masotti A (2012). Bioinformatics Tools and Novel Challenges in Long Non-Coding RNAs (lncRNAs). Functional Analysis. Int J Mol Sci, 13, 97-114.
10. de Kok JB, Verhaegh GW, Roelofs RW, et al (2002). DD3 (PCA3)., a very sensitive and specific marker to detect prostate tumors. Cancer Res, 62, 2695-8.
11. Dexter DL, Kowalski HM, Blazar BA, et al (1978). Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res, 38, 3174-81.
12. Fejes-Toth K, Sotirova V, Sachidanandam R, et al (2009). Post-transcriptional processing generates a diversity of 5'-modified long and short RNAs. Nature, 457, 1028-32.
13. Fritah A, Saucier C, De Wever O, et al (2008). Role of WISP-2/CCN5 in the maintenance of a differentiated and noninvasive phenotype in human breast cancer cells. Mol Cell Biol, 28, 1114-23.
14. Genda T, Ichida T, Kojiro M, et al (1999). Cell motility mediated by Rho and Rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma. Hepatology, 30, 1027-36.
15. Gesierich S, Berezovskiy I, Ryschich E, et al (2006). Systemic induction of the angiogenesis switch by the tetraspanin D6.1A/CO-029. Cancer Res, 66, 7083-94.
16. Guo FJ, Li YL, Liu Y, et al (2010). Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion. Acta Biochim Biophys Sin, 42, 224-9.
17. Gupta RA, Shah N, Wang KC, et al (2010). Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature, 464, 1071-6.
18. Guttman M, Amit I, Garber M, et al (2009). Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature, 458, 223-7.
19. Guttman M, Donaghey J, Carey BW, et al (2011). lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature, 477, 295-300.
20. Guttman M, Rinn JL (2012). Modular regulatory principles of large non-coding RNAs. Nature, 482, 339-46.
21. Hanahan D, Weinberg RA (2011). Hallmarks of cancer: the next generation. Cell, 144, 646-74.
22. He Y, Meng XM, Huang C, et al (2014). Long noncoding RNAs: Novel insights into hepatocelluar carcinoma. Cancer Lett, 344, 20-7.
23. Hibi K, Nakamura H, Hirai A, et al (1996). Loss of H19 imprinting in esophageal cancer. Cancer Res, 56, 480-2.
24. Hong SS, Kim TK, Sung KB, et al (2003). Extrahepatic spread of hepatocellular carcinoma: a pictorial review. Eur Radiol, 13, 874-82.
25. Iacoangeli A, Lin Y, Morley EJ, et al (2004). BC200 RNA in invasive and preinvasive breast cancer. Carcinogenesis, 25, 2125-33.
26. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA-Cancer J Clin, 61, 69-90.
27. Ji P, Wang WB, Metzger R, et al (2003). MALAT-1, a novel noncoding RNA, and thymosin beta 4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene, 22, 8031-41.
28. Kanetaka K, Sakamoto M, Yamamoto Y, et al (2001). Overexpression of tetraspanin CO-029 in hepatocellular carcinoma. J Hepatol, 35, 637-42.
29. Kanetaka K, Sakamoto M, Yamamoto Y, et al (2003). Possible involvement of tetraspanin CO-029 in hematogenous intrahepatic metastasis of liver cancer cells. J Gastroenterol Hepatol, 18, 1309-14.
30. Kapranov P, Cawley SE, Drenkow J, et al (2002). Large-scale transcriptional activity in chromosomes 21 and 22. Science, 296, 916-9.
31. Khalil AM, Guttman M, Huarte M, et al (2009). Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A, 106, 11667-72.
32. Kmita M, Duboule D (2003). Organizing axes in time and space; 25 years of colinear tinkering. Science, 301, 331-3.
33. Lemons D, McGinnis W (2006). Genomic evolution of Hox gene clusters. Science, 313, 1918-22.
34. Li Y, Tang Y, Ye L, et al (2003). Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J Cancer Res Clin Oncol, 129, 43-51.
35. Li Y, Tang ZY, Ye SL, et al (2001). Establishment of cell clones with different metastatic potential from the metastatic hepatocellular carcinoma cell line MHCC97. World J Gastroenterol, 7, 630-6.
36. Lin R, Maeda S, Liu C, et al (2007). A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene, 26, 851-8.
37. Llovet JM, Lencioni R, Gaile PR, et al (2012). EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol, 56, 908-43.
38. Lu X, Kang Y (2007). Organotropism of breast cancer metastasis. J Mammary Gland Biol Neoplasia, 12, 153-62.
39. Matouk IJ, Abbasi I, Hochberg A, et al (2009). Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis. Eur J Gastroenterol Hepatol, 21, 688-92.
40. Mercer TR, Dinger ME, Mattick JS (2009). Long non-coding RNAs: insights into functions. Nat Rev Genet, 10, 155-9.
41. Mootha VK, Lindgren CM, Eriksson KF, et al (2003). PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet, 34, 267-73.
42. Mourtada-Maarabouni M, Pickard MR, Hedge VL, et al (2009). GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene, 28, 195-208.
43. Nguyen DX, Bos PD, Massague J (2009). Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer, 9, 274-84.
44. Nupponen NN, Carpten JD (2001). Prostate cancer susceptibility genes: many studies, many results, no answers. Cancer Metastasis Rev, 20, 155-64.
45. Ohta M, Seto M, Miyabayashi K, et al (2009). Decreased expression of the RAS-GTPase activating protein RASAL1 is associated with colorectal tumor progression. Gastroenterology, 136, 206-16.
46. Okazaki Y, Furuno M, Kasukawa T, et al (2002). Analysis of the mouse transcriptome based on functional annotation of 60, 770 full-length cDNAs. Nature, 420, 563-73.
47. Orom UA, Derrien T, Beringer M, et al (2010). Long Noncoding RNAs with Enhancer-like Function in Human Cells. Cell, 143, 46-58.
48. Panzitt K, Tschernatsch MM, Guelly C, et al (2007). Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA. Gastroenterology, 132, 330-42.
49. Pibouin L, Villaudy J, Ferbus D, et al (2002). Cloning of the mRNA of overexpression in colon carcinoma-1: a sequence overexpressed in a subset of colon carcinomas. Cancer Genet Cytogenet, 133, 55-60.
50. Ponting CP, Oliver PL, Reik W (2009). Evolution and Functions of Long Noncoding RNAs. Cell, 136, 629-41.
51. Poon R, Wong J (2000). Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg, 232.
52. Prieto C, Risueno A, Fontanillo C, et al (2008). Human gene coexpression landscape: confident network derived from tissue transcriptomic profiles. PLoS Onee, 3.
53. Qiao HP, Gao WS, Huo JX, et al (2013). Long non-coding RNA GAS5 functions as a tumor suppressor in renal cell carcinoma. Asian Pac J Cancer Prev, 14, 1077-82.
54. Qiu MT, Hu JW, Yin R, et al (2013). Long noncoding RNA: an emerging paradigm of cancer research. Tumour Biol, 34, 613-20.
55. Rangel L, Wernyj RP, Cho KR (2003). Characterization of novel human ovarian cancer-specific transcripts (HOSTs). identified by serial analysis of gene expression. Oncogene, 22, 7225-32.
56. Ren S, Wang F, Shen J, et al (2013). Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. Eur J Cancer, 49, 2949-59.
57. Rinn JL, Wang JK, Xu X, et al (2007). Functional demarcation of active and silent chromatin domains in human HOX loci by Noncoding RNAs. Cell, 129, 1311-23.
58. Seto M, Ohta M, Ikenoue T, et al (2011). Reduced expression of RAS protein activator like-1 in gastric cancer. Int J Cancer, 128, 1293-302.
59. Simon JA, Kingston RE (2009). Mechanisms of Polycomb gene silencing: knowns and unknowns. Nat Rev Mol Cell Biol, 10, 697-708.
60. Smedley D, Sidhar S, Birdsall S, et al (2000). Characterization of chromosome 1 abnormalities in malignant melanomas. Genes Chromosomes Cancer, 28, 121-5.
61. Sporn JC, Kustatscher G, Hothorn T, et al (2009). Histone macroH2A isoforms predict the risk of lung cancer recurrence. Oncogene, 28, 3423-8.
62. Subramanian A, Tamayo P, Mootha VK, et al (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA, 102, 15545-50.
63. Sun FX, Tang ZY, Lui KD, et al (1996). Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues. Int J Cancer, 66, 239-43.
64. Taft RJ, Pang KC, Mercer TR, et al (2010). Non-coding RNAs: regulators of disease. J Pathol, 220, 126-39.
65. Talmadge JE, Fidler IJ (2010). AACR Centrspective. Cancer Res, 70, 5649-69.
66. Tinzl M, Horvath S (2004). DD3 (PCA3). RNA analysis in urine-A new perspective for detecting prostate cancer. Eur Urol, 46, 182-7.
67. Uchino H, Kataoka H, Itoh H, et al (2000). Overexpression of intestinal trefoil factor in human colon carcinoma cells reduces cellular growth in vitro and in vivo. Gastroenterol, 118, 60-9.
68. Wang JY, Liu XF, Wu HC, et al (2010). CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer. Nucleic Acids Res, 38, 5366-83.
69. Wang Y, Liu XJ, Yao XD (2014). Function of PCA3 in prostate tissue and clinical research progress on developing a PCA3 score. Chin J Cancer Res, 26, 493-500.
70. Wapinski O, Chang HY (2011). Long noncoding RNAs and human disease. Trends Cell Biol, 21, 354-61.
71. Wilusz JE, Sunwoo H, Spector DL (2009). Long noncoding RNAs: functional surprises from the RNA world. Genes Dev, 23, 1494-504.
72. Xie H, Ma H, Zhou D (2013). Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma. Biomed Res Int, 2013, 136106.
73. Yamada K, Kano J, Tsunoda H, et al (2006). Phenotypic characterization of endometrial stromal sarcoma of the uterus. Cancer Sci, 97, 106-12.
74. Yang F, Zhang L, Huo XS, et al (2011). Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology, 54, 1679-89.
75. Ye QH, Forgues M, Kim JW, et al (2003). Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med, 9, 416-23.
76. Yue S, Mu W, Zoller M (2013). Tspan8 and CD151 promote metastasis by distinct mechanisms. Eur J Cancer, 49, 2934-48.
77. Zhang EB, Han L, Yin DD, et al (2014). c-Myc-induced, long, noncoding H19 affects cell proliferation and predicts a poor prognosis in patients with gastric cancer. Med Oncol, 31, 914.
78. Zhang H, Cai K, Wang J, et al (2014). MiR-7, Inhibited indirectly by lincRNA HOTAIR, directly inhibits SETDB1 and reverses the EMT of breast cancer stem cells by downregulating the STAT3 pathway. Stem Cells, 32, 2858-68.